CN103585450A

CN103585450A - Drug composition for treating chronic pharyngitis

Info

Publication number: CN103585450A
Application number: CN201310580275.2A
Authority: CN
Inventors: 钱家美
Original assignee: Individual
Current assignee: Individual
Priority date: 2013-11-19
Filing date: 2013-11-19
Publication date: 2014-02-19

Abstract

The invention discloses a drug composition for treating chronic pharyngitis. The drug composition is prepared by mixing radix scrophulariae, radix ophiopogonis, radix polygonati officinalis, blackberry lily, vitex, almonds, liquorice, chrysanthemum, alum and bingpeng powder. A clinical verification shows that the drug composition is quick-acting, good in treatment effect, convenient to take and worthy of popularization and application.

Description

A kind of pharmaceutical composition for the treatment of chronic pharyngitis

Technical field

The present invention relates to a kind of pharmaceutical composition for the treatment of chronic pharyngitis.

Background technology

Chronic pharyngitis is a kind of commonly encountered diseases, for the pharyngeal pathological changes of the caused diffusivity of chronic infection, is mainly pharyngeal mucosa inflammation.Be mainly in adult, its Etiological has sends out acute pharyngitis, long-term dust or harmful gas stimulation, tobacco and wine excessively or other bad life habits, the stimulation of sinusitis part secretion, allergic constitution or passive protective physical fitness attenuating etc. repeatly.Chronic pharyngitis can be also the topical manifestations of some systemic disease, as anemia, diabetes, liver cirrhosis and chronic nephritis etc.

Chronic pharyngitis is frequently-occurring disease, and the course of disease is long, and symptom is obstinate, treatment difficulty.The early stage red swelling of the pharynx of this disease is congested, and pharynx rear wall lymph follicle increases, and can have mucus part secretion, and can there be mucosa in the later stage, and retropharyneal folliculosis or company adjoin in flakes.Show as the pharyngeal various uncomfortable sensations that have, as foreign body sensation, itch, scorching hot, dry, hypodynia, dry cough, abundant expectoration is mucofilin not, and speech is easily tired, or gargles in brushing teeth, and talks when many and easily feels sick and feel sick.

Chronic pharyngitis is difficult to thoroughly radical cure, and relapse rate height is its outstanding feature, present stage primary treatment method have medicine composite for curing, western medicine, the method for the combination of Chinese and Western medicine and some auxiliary treatment, as acupuncture, microwave, atomization suction etc.For common patient, need to there is a kind of determined curative effect, can quick acting and the convenient medicine using.

Summary of the invention

Technical problem to be solved by this invention is to provide a kind of pharmaceutical composition for the treatment of chronic pharyngitis, requires said composition therapeutic effect good, takes simple.

For solving the problems of the technologies described above, the invention provides a kind of pharmaceutical composition for the treatment of chronic pharyngitis, by the medicine material of following weight portion, formed: Radix Scrophulariae 10-15 part, Radix Ophiopogonis 10-15 part, Rhizoma Polygonati Odorati 10-15 part, Rhizoma Belamcandae 5-10 part, Herba Viticis Cannabifoliae 5-10 part, Semen Armeniacae Amarum 5-10 part, Radix Glycyrrhizae 5-10 part, Flos Chrysanthemi 5-10 part, Alumen 5-7 part, BINGPENG SAN 5-7.As optimization of the present invention, described pharmaceutical composition is comprised of the medicine material of following weight portion: 10 parts of Radix Scrophulariaes, 10 parts of Radix Ophiopogonis, 10 parts of Rhizoma Polygonati Odorati, 10 parts of Rhizoma Belamcandae, 10 parts of Herba Viticis Cannabifoliaes, 7 parts, Semen Armeniacae Amarum, 7 parts, Radix Glycyrrhizae, 7 parts of Flos Chrysanthemis, 5 parts of Alumens, 5 parts of BINGPENG SAN.

Described pharmaceutical composition preparation method is simple, just the Radix Scrophulariae in aforementioned pharmaceutical compositions, Radix Ophiopogonis, Rhizoma Polygonati Odorati, Rhizoma Belamcandae, Herba Viticis Cannabifoliae, Semen Armeniacae Amarum, Radix Glycyrrhizae, Flos Chrysanthemi mix, the water that adds approximately 4 times of volumes, after boiled, 2-3 hour at a simmer, while being cooled to 20-30 ℃, add Alumen, BINGPENG SAN, fill after part dissolving.While taking, take each 8-10mL every day 3 times.

In the present invention, Radix Scrophulariae is controlled calentura excessive thirst, sends out speckle, and hectic fever due to YIN-deficiency consumptive fever, sleeps not peaceful night, spontaneous sweating, and constipation is hindered in Tianjin, hematemesis and epistaxis, laryngopharynx swelling and pain, carbuncle, scrofula.Can be used for eliminating fire and detoxication, for the various heat syndromes of excessive noxious heat, get the effect of its clearing away heat-fire removing toxic substances, treatment heating, pharyngeal swelling, conjunctival congestion, furuncle, necrosis etc.

Radix Ophiopogonis: YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.For dryness of the lung dry cough, chronic consumptive disease cough, Tianjin wound is thirsty, vexed insomnia, interior-heat is quenched one's thirst, dryness of the intestine constipation, pharyngeal diphtheria.YIN nourishing and the production of body fluid promoting, nourishing the lung to arrest cough: for few thirsty, the dry cough spitting of blood in Tianjin of lung-stomach yin deficiency; The cards such as the palpitation and being susceptible to fright of insufficiency of heart-YIN and calentura later stage consumption of body fluid by heat.

Rhizoma Polygonati Odorati is applicable to lung stomach-Yin wound, deficiency of body fluid, dry throat and mouth, the few person of dry cough expectorant.

Rhizoma Belamcandae: heat-clearing and toxic substances removing, sore-throat relieving eliminates the phlegm.

Herba Viticis Cannabifoliae, Semen Armeniacae Amarum expelling pathogenic wind from the body surface, phlegm-eliminiating and qi-regulating.

Radix Glycyrrhizae, Flos Chrysanthemi clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.

Above-mentioned all medicines share, and gather altogether the effect of resolving toxin and disinhibiting the throat.

The pharmaceutical composition for the treatment of chronic pharyngitis of the present invention, through clinic trial, this medicine instant effect, good effect, taking convenience.

The specific embodiment

Below by embodiment, further illustrate the present invention.

Embodiment: described pharmaceutical composition is comprised of the medicine material of following weight portion: 10 parts of Radix Scrophulariaes, 10 parts of Radix Ophiopogonis, 10 parts of Rhizoma Polygonati Odorati, 10 parts of Rhizoma Belamcandae, 10 parts of Herba Viticis Cannabifoliaes, 7 parts, Semen Armeniacae Amarum, 7 parts, Radix Glycyrrhizae, 7 parts of Flos Chrysanthemis, 5 parts of Alumens, 5 parts of BINGPENG SAN.

Test report:

Get outpatient's 142 examples, random part treatment group and matched group.Treatment group 72 examples, the oldest 60 years old, minimum 15 years old, male, 32 examples, women's 40 examples, the course of disease is the longest 12 years, the shortest 5 months.

Matched group 70 examples, the oldest 60 years old, minimum 14 years old, male's 41 examples, women's 29 examples, the course of disease is the longest 11 years, the shortest 5 months.

Two groups of sexes, age, the comparison of course of disease situation, two groups of data no significant differences, have comparability.

Therapeutic Method: the drug ratio of the treatment group application embodiment of the present invention is treated, ten days is a curative effect, one the course for the treatment of observe the curative effect.Matched group buccal Qingyan Lihou tablets and New Oral Gold are really drunk oral liquid observe the curative effect, within ten days, are a curative effect.

Therapeutic outcome:

Two groups of patients with chronic pharyngitis are all through a course of therapy observed result:

Treatment group: cure 50 examples, 20 examples that take a turn for the better, 2 examples that do not heal, effective percentage 97.4%.

Matched group: cure 17 examples, 10 examples that take a turn for the better, 43 examples that do not heal, effective percentage 38.6%.

Treatment group therapeutic effect is obviously better than matched group.

Claims

1. treat a pharmaceutical composition for chronic pharyngitis, by the medicine material of following weight portion, formed: Radix Scrophulariae 10-15 part, Radix Ophiopogonis 10-15 part, Rhizoma Polygonati Odorati 10-15 part, Rhizoma Belamcandae 5-10 part, Herba Viticis Cannabifoliae 5-10 part, Semen Armeniacae Amarum 5-10 part, Radix Glycyrrhizae 5-10 part, Flos Chrysanthemi 5-10 part, Alumen 5-7 part, BINGPENG SAN 5-7.

2. according to a kind of pharmaceutical composition for the treatment of chronic pharyngitis described in claim l, it is characterized in that: the medicine material by following weight portion forms: 10 parts of Radix Scrophulariaes, 10 parts of Radix Ophiopogonis, 10 parts of Rhizoma Polygonati Odorati, 10 parts of Rhizoma Belamcandae, 10 parts of Herba Viticis Cannabifoliaes, 7 parts, Semen Armeniacae Amarum, 7 parts, Radix Glycyrrhizae, 7 parts of Flos Chrysanthemis, 5 parts of Alumens, 5 parts of BINGPENG SAN.